Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

New melanogenesis inhibitor isolated from actinomycete

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

MedImmune seeks FDA approval for psoriasis trials with MEDI-507

Nov. 28, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

New histamine antagonists described for dermatological indications

Nov. 21, 1997

Phase II begins for psoriasis vaccine

Nov. 20, 1997

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...